Spexin, a neuropeptide in the galanin family, has been shown to activate GALR2/GALR3 (but not GALR1) and mitigate diet-induced hepatic steatosis in vivo and in vitro by activating GALR2. This evidence concerns the gene GAL and fatty liver disease.